Evidence map›Paper›PMID 42441312›Full record

ArticleFrontiers in medicine2026

Mast cell burden and immunophenotype of Chinese patients with cutaneous mastocytosis: a 10-year study with focus on the easily neglected pathogenic features.

Qiannan Jia, Xinran Li, Aiping Fan, Dian Zheng, Shuaixin Li, Weiqi Wang, Siying Li, Jun Li

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiannan Jia *Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xinran Li *Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Aiping Fan *Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Dian ZhengDepartment of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shuaixin LiDepartment of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Weiqi WangDepartment of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Siying LiDepartment of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jun LiDepartment of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cutaneous mastocytosis (CM) is a heterogeneous disease. Challenges remain in the detailed pathological features and pathogenic factors and their potential correlation in Chinese patients. Objective: This study aimed to characterize the pathological features and immunophenotypes of different CM subtypes in a real-world cohort and to explore the potential correlations between mast cell-related pathogenic features and clinical phenotypes. Methods: A cohort of 88 patients diagnosed with CM by histopathological examination in the Department of Dermatology between 2015 and 2024 was established. Immunohistochemical and clinicopathological analyses were performed. Results: Mast cell burden is associated with CM subtype, with the lowest burden being in telangiectasia macularis eruptive perstans (TMEP), followed by urticaria pigmentosa (UP) and diffuse CM/mastocytoma. High mast cell burden may also be associated with specific clinical morphology (e.g., elevated lesions) and an earlier age of onset. Different clinical subtypes exhibit distinct immunophenotypes. The expression of CD2, CD25, and CD30 may correlate with specific subtypes with high mast cell burden and provide potential value for CM diagnosis and subtyping. TMEP showed pathological differences from other subtypes, particularly in mast cell burden and immunophenotype. Conclusion: Different CM subtypes display distinct mast cell burdens and immunophenotypes, suggesting potential diagnostic value. The diverse clinical phenotypes may be associated with different mast cell burdens. TMEP may represent a unique and rare morphological variant of UP.

Indexed as

cutaneous mastocytosisimmunophenotypemaculopapular cutaneous mastocytosismastocytosispathological featuretelangiectasia macularis eruptive perstans

Identifiers

PMID42441312
PMCPMC13335676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.